|
1
|
Frolkis A, Dieleman LA, Barkema HW,
Panaccione R, Ghosh S, Fedorak RN, Madsen K and Kaplan GG: Alberta
IBD Consortium: Environment and the inflammatory bowel diseases.
Can J Gastroenterol. 27:e18–e24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maloy KJ and Powrie F: Intestinal
homeostasis and its breakdown in inflammatory bowel disease.
Nature. 474:298–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Danese S and Fiocchi C: Etiopathogenesis
of inflammatory bowel diseases. World J Gastroenterol.
12:4807–4812. 2006.PubMed/NCBI
|
|
4
|
Triantafillidis JK, Merikas E and
Georgopoulos F: Current and emerging drugs for the treatment of
inflammatory bowel disease. Drug Des Devel Ther. 5:185–210. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xian YF, Suo J, Huang XD, Hou SZ, Chen J,
Ye M and Su ZR: A Pharmacological Study on Anti-inflammatory
Effects of Refined Huodan Recipe. Zhong Guo Shi Yan Fang Ji Xue Za
Zhi She. 13:54–56. 2007.(In Chinese).
|
|
6
|
Qi SS, Hu LP, Chen WN, Sun HB and Ma XD:
Immunological regulation effects of essential oil in leaves of
Cablin Patchouli herbal on mice. Chin Arch Trad Chin Med.
27:774–776. 2009.
|
|
7
|
Yang X, Zhang X, Yang SP and Liu WQ:
Evaluation of the antibacterial activity of patchouli oil. Iran J
Pharm Res. 12:307–316. 2013.PubMed/NCBI
|
|
8
|
Mizoguchi A and Mizoguchi E: Animal models
of IBD: Linkage to human disease. Curr Opin Pharmacol. 10:578–587.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu X, Zhao X, Bai C, Zhao C, Lu G and Xu
G: LC-MS-based metabonomics analysis. J Chromatogr B Analyt Technol
Biomed Life Sci. 866:64–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang XJ, Choi FF, Zhou Y, Leung FP, Tan
S, Lin S, Xu H, Jia W, Sung JJ, Cai Z and Bian Z: Metabolite
profiling of plasma and urine from rats with TNBS-induced acute
colitis using UPLC-ESI-QTOF-MS-based metabonomics-a pilot study.
FEBS J. 279:2322–2338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin RF, Feng XX, Li CW, Zhang XJ, Yu XT,
Zhou JY, Zhang X, Xie YL, Su ZR and Zhan JY: Prevention of UV
radiation-induced cutaneous photoaging in mice by topical
administration of patchouli oil. J Ethnopharmacol. 154:408–418.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McCafferty DM, Sharkey KA and Wallace JL:
Beneficial effects of local or systemic lidocaine in experimental
colitis. Am J Physiol. 266:G560–G567. 1994.PubMed/NCBI
|
|
13
|
Cooper HS, Murthy SN, Shah RS and
Sedergran DJ: Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab Invest. 69:238–249.
1993.PubMed/NCBI
|
|
14
|
Gue M, Bonbonne C, Fioramonti J, Moré J,
Del Rio-Lachèze C, Coméra C and Buéno L: Stress-induced enhancement
of colitis in rats: CRF and arginine vasopressin are not involved.
Am J Physiol. 272:G84–G91. 1997.PubMed/NCBI
|
|
15
|
Schicho R and Storr M: Topical and
systemic cannabidiol improves trinitrobenzene sulfonic acid colitis
in mice. Pharmacology. 89:149–155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Best WR, Becktel JM, Singleton JW and Kern
F Jr: Development of a Crohn's disease activity index. National
cooperative crohn's disease study. Gastroenterology. 70:439–444.
1976.PubMed/NCBI
|
|
17
|
Krawisz JE, Sharon P and Stenson WF:
Quantitative assay for acute intestinal inflammation based on
myeloperoxidase activity. Assessment of inflammation in rat and
hamster models. Gastroenterology. 87:1344–1350. 1984.PubMed/NCBI
|
|
18
|
Zhang YZ and Li YY: Inflammatory bowel
disease: Pathogenesis. World J Gastroenterol. 20:91–99. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guarner F: The intestinal flora in
inflammatory bowel disease: Normal or abnormal? Curr Opin
Gastroenterol. 21:414–418. 2005.PubMed/NCBI
|
|
20
|
Stephani J, Radulovic K and Niess JH: Gut
microbiota, probiotics and inflammatory bowel disease. Arch Immunol
Ther Exp (Warsz). 59:161–177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yap IK, Li JV, Saric J, Martin FP, Davies
H, Wang Y, Wilson ID, Nicholson JK, Utzinger J, Marchesi JR and
Holmes E: Metabonomic and microbiological analysis of the dynamic
effect of vancomycin-induced gut microbiota modification in the
mouse. J Proteome Res. 7:3718–3728. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akira K, Hichiya H, Morita M, Shimizu A
and Mitome H: Metabonomic study on the biochemical response of
spontaneously hypertensive rats to chronic taurine supplementation
using (1)H NMR spectroscopic urinalysis. J Pharm Biomed Anal.
85:155–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Walsh MC, Brennan L, Pujos-Guillot E,
Sébédio JL, Scalbert A, Fagan A, Higgins DG and Gibney MJ:
Influence of acute phytochemical intake on human urinary
metabolomic profiles. Am J Clin Nutr. 86:1687–1693. 2007.PubMed/NCBI
|
|
24
|
Akira K, Masu S, Imachi M, Mitome H and
Hashimoto T: A metabonomic study of biochemical changes
characteristic of genetically hypertensive rats based on (1)H NMR
spectroscopic urinalysis. Hypertens Res. 35:404–412. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Del A, ngel-Meza AR, Dávalos-Marín AJ,
Ontiveros-Martinez LL, Ortiz GG, Beas-Zarate C, Chaparro-Huerta V,
Torres-Mendoza BM and Bitzer-Quintero OK: Protective effects of
tryptophan on neuro-inflammation in rats after administering
lipopolysaccharide. Biomed Pharmacother. 65:215–219. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim CJ, Kovacs-Nolan JA, Yang C, Archbold
T, Fan MZ and Mine Y: l-Tryptophan exhibits therapeutic function in
a porcine model of dextran sodium sulfate (DSS)-induced colitis. J
Nutr Biochem. 21:468–475. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Frumento G, Rotondo R, Tonetti M, Damonte
G, Benatti U and Ferrara GB: Tryptophan-derived catabolites are
responsible for inhibition of T and natural killer cell
proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med.
196:459–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nguyen NT, Kimura A, Nakahama T, Chinen I,
Masuda K, Nohara K, Fujii-Kuriyama Y and Kishimoto T: Aryl
hydrocarbon receptor negatively regulates dendritic cell
immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad
Sci USA. 107:pp. 19961–19966. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Linden DR, Chen JX, Gershon MD, Sharkey KA
and Mawe GM: Serotonin availability is increased in mucosa of
guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest
Liver Physiol. 285:G207–G216. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gersemann M, Wehkamp J and Stange EF:
Innate immune dysfunction in inflammatory bowel disease. J Intern
Med. 271:421–428. 2012. View Article : Google Scholar : PubMed/NCBI
|
